Evidence-based incorporation of serum sodium concentration into MELD.

By S. Biggins, W. Kim, N. Terrault, S. Saab, V. Balan, T. Schiano, J. Benson, Terry M. Therneau, W. Kremers, R. Wiesner and 2 more. Gastroenterology, 2006

795 citations recorded by the source corpus.

Subfields: Hepatology, Nutrition and Dietetics, Surgery

View Paper: https://www.semanticscholar.org/paper/cb58fe2b82d515087a83e162c9fd9af5604c17ca

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Hepatology

1. P. Ginés
2. M. Bernardi
3. P. Angeli
4. W. Laleman
5. J. Trebicka
6. Rajeshwar P. Mookerjee
7. D. Sarkar
8. G. Garcia‐Tsao

In Surgery

1. P. Ginés

Citations in the corpus

• Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases (2021, background): “Many patients with RA also have hyponatremia, which is addressed by the model for end-stage liver disease-soduim (MELDNa) score (98-101).”
• Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification (2020, methodology): “In 2006, the MELD score was updated to include serum sodium levels and referred to as MELD-Na (Biggins et al., 2006).”
• EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. (2018, methodology): “Incorporating serum sodium concentration into MELD score, a new score (MELD-Na) was generated that provides more accurate survival prediction than MELD alone [149], especially in patients with ascites and hyponatremia with intermediate MELD score values [150].”